What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?

What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?


Few things are as inevitable and frustrating as generic competition in the pharma industry. After overcoming the high risks of failure in drug development and pouring money into sales and marketing, the owner of a successful drug can see its revenue plunge overnight when generic copycats come onto the scene.



from Biotech News